HRP20010128B1 - Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method - Google Patents

Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method

Info

Publication number
HRP20010128B1
HRP20010128B1 HR20010128A HRP20010128A HRP20010128B1 HR P20010128 B1 HRP20010128 B1 HR P20010128B1 HR 20010128 A HR20010128 A HR 20010128A HR P20010128 A HRP20010128 A HR P20010128A HR P20010128 B1 HRP20010128 B1 HR P20010128B1
Authority
HR
Croatia
Prior art keywords
compound
preparation
antifungic
coat
activity
Prior art date
Application number
HR20010128A
Other languages
English (en)
Inventor
Carlos Picornell Darder
Original Assignee
Liconsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010128(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa filed Critical Liconsa
Publication of HRP20010128A2 publication Critical patent/HRP20010128A2/hr
Publication of HRP20010128B1 publication Critical patent/HRP20010128B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HR20010128A 1998-07-21 2001-02-21 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method HRP20010128B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (2)

Publication Number Publication Date
HRP20010128A2 HRP20010128A2 (en) 2002-12-31
HRP20010128B1 true HRP20010128B1 (en) 2003-12-31

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010128A HRP20010128B1 (en) 1998-07-21 2001-02-21 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method

Country Status (31)

Country Link
US (1) US6737082B1 (de)
EP (1) EP1103252B1 (de)
JP (1) JP4190732B2 (de)
KR (1) KR100572135B1 (de)
AT (1) ATE234077T1 (de)
AU (1) AU750730B2 (de)
BG (1) BG65187B1 (de)
BR (1) BR9912300A (de)
CA (1) CA2337509C (de)
CZ (1) CZ291938B6 (de)
DE (1) DE69905905T2 (de)
DK (1) DK1103252T3 (de)
EE (1) EE04415B1 (de)
ES (2) ES2157731B1 (de)
HK (1) HK1037531A1 (de)
HR (1) HRP20010128B1 (de)
HU (1) HU228895B1 (de)
IL (1) IL140910A (de)
ME (1) MEP26708A (de)
MX (1) MXPA01000681A (de)
NO (1) NO320054B1 (de)
NZ (1) NZ509886A (de)
PL (1) PL194740B1 (de)
PT (1) PT1103252E (de)
RS (1) RS50063B (de)
RU (1) RU2209628C2 (de)
SK (1) SK283279B6 (de)
TR (1) TR200100177T2 (de)
UA (1) UA64009C2 (de)
WO (1) WO2000004881A1 (de)
ZA (1) ZA200101293B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU722050B2 (en) * 1996-01-31 2000-07-20 South Alabama Medical Science Foundation Food and vitamin preparations containing the natural isomer of reduced folates
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
MXPA02006324A (es) 1999-12-23 2002-12-13 Pfizer Prod Inc Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco.
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
ES2283725T5 (es) * 2003-01-14 2014-11-28 Acino Pharma Ag Composición bioequivalente de itraconazol dispersada en un polímero hidrófilo
SI1438960T2 (sl) * 2003-01-14 2013-04-30 Cimex Pharma Ag Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
US20060172010A1 (en) 2003-07-17 2006-08-03 Gael Lamoureux Process for preparing particles containing an antiviral
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
JP5435946B2 (ja) 2005-08-22 2014-03-05 ジョンズ ホプキンス ユニバーシティ 疾患を処置するためのヘッジホッグ経路アンタゴニスト
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP2542222A2 (de) * 2010-03-05 2013-01-09 Basf Se Schmelzüberzogene arzneiformen
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
WO2016189481A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once daily oral pharmaceutical composition of isotretinoin
KR102419769B1 (ko) 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DK0904060T3 (da) * 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
ES2169440T3 (es) * 1996-05-24 2002-07-01 Schering Corp Composiciones antifungicas con biodisponibilidad mejorada.
HUP9903869A3 (en) * 1996-06-28 2000-07-28 Schering Corp Oral composition comprising a triazole antifungal compound
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
PT969821E (pt) 1997-03-26 2003-10-31 Janssen Pharmaceutica Nv Pastilhas tendo um nucleo revestido com um antifungico e um polimero

Also Published As

Publication number Publication date
DE69905905T2 (de) 2004-03-04
NO20010289L (no) 2001-03-07
JP2002521323A (ja) 2002-07-16
NZ509886A (en) 2002-09-27
HUP0103708A3 (en) 2002-07-29
HK1037531A1 (en) 2002-02-15
DK1103252T3 (da) 2003-07-14
HU228895B1 (en) 2013-06-28
NO20010289D0 (no) 2001-01-17
UA64009C2 (en) 2004-02-16
ATE234077T1 (de) 2003-03-15
NO320054B1 (no) 2005-10-17
AU750730B2 (en) 2002-07-25
AU4782199A (en) 2000-02-14
TR200100177T2 (tr) 2001-07-23
PT1103252E (pt) 2003-07-31
HRP20010128A2 (en) 2002-12-31
DE69905905D1 (de) 2003-04-17
BG65187B1 (bg) 2007-06-29
ES2157731A1 (es) 2001-08-16
PL194740B1 (pl) 2007-06-29
CZ291938B6 (cs) 2003-06-18
WO2000004881A1 (es) 2000-02-03
EE04415B1 (et) 2005-02-15
CA2337509C (en) 2005-12-27
MEP26708A (en) 2010-06-10
ZA200101293B (en) 2001-08-21
MXPA01000681A (es) 2002-04-24
SK862001A3 (en) 2001-08-06
EE200100041A (et) 2002-06-17
JP4190732B2 (ja) 2008-12-03
ES2157731B1 (es) 2002-05-01
HUP0103708A2 (hu) 2002-02-28
KR20010070990A (ko) 2001-07-28
US6737082B1 (en) 2004-05-18
RS50063B (sr) 2009-01-22
RU2209628C2 (ru) 2003-08-10
IL140910A (en) 2004-03-28
CZ2001175A3 (en) 2001-05-16
IL140910A0 (en) 2002-02-10
PL345625A1 (en) 2002-01-02
SK283279B6 (sk) 2003-05-02
CA2337509A1 (en) 2000-02-03
KR100572135B1 (ko) 2006-04-19
YU3901A (sh) 2003-08-29
BR9912300A (pt) 2001-04-17
BG105282A (en) 2001-11-30
EP1103252B1 (de) 2003-03-12
ES2194480T3 (es) 2003-11-16
EP1103252A1 (de) 2001-05-30

Similar Documents

Publication Publication Date Title
HRP20010128B1 (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
DE69431807T2 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
AU2940200A (en) Hydrophilic member, method for preparation thereof, and coating agent and apparatus for preparation thereof
AU3100700A (en) Antibiotic hydrophilic polymer coating
CA2314078A1 (en) Coating of polymers
EP0351760A3 (de) Futterzusatzmittel für Wiederkäuer
HUT50050A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions
CA2370067A1 (en) Pharmaceutical dosage forms for controlled release producing at least a timed pulse
HK1011182A1 (en) Method for manufacturing sustained release particles
DE69100670D1 (de) Eine Suspension hydratisierter Spheroide einer hydrophilen Lipidsubstanz enthaltendes wässriges kosmetisches bzw. dermopharmazeutisches Mittel.
AU2307402A (en) Microgranules based on active principle and method for making same
EP1145708A3 (de) Kosmetische Zusammensetzung und deren Verwendung
GR3023584T3 (en) A solid pharmaceutical dosage form and a method for reducing abrasion.
EP0998944A3 (de) Enterisch überzogene Formulierung eines Benzimidazol-Derivates und Verfahren deren Herstellung
EP1417960A4 (de) Mikrokügelchen mit verzögerter freisetzung und verfahren zu ihrer herstellung
Roders Application of coating of the die casting dies
ES8800838A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: LABORATORIOS LICONSA, S.A., ES

ODRP Renewal fee for the maintenance of a patent

Payment date: 20130709

Year of fee payment: 15

PBON Lapse due to non-payment of renewal fee

Effective date: 20140720